- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-32-0009470

Rascure Pharmaceuticals Private Limited
About Rascure Pharmaceuticals Private Limited
Data last updated:
Rascure Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 22 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC309584.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amit Kumar Srivastva and Ravi Pratap Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 527 – A Kh.No. 962/1/2 S/F Front Side Vts Garden Chatarpur Extn., New Delhi, Delhi, India – 110074.
As per the financials filed for FY 2024, the company reported a revenue of ₹65.86 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹71,260 (net margin 1.1%) and EBITDA of ₹1.71 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years and 57% over five years.
Rascure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0009470). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Rascure Pharmaceuticals
Contact details
Rascure Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressC – 527 – A Kh.No. 962/1/2 S/F Front Side Vts Garden Chatarpur Extn., New Delhi, Delhi, India – 110074
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rascure Pharmaceuticals is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Rascure Pharmaceuticals Private Limited, buy the company report.
Financials of Rascure Pharmaceuticals Private Limited
FY 2024 filings availableRascure Pharmaceuticals Private Limited reported revenue of ₹65.86 Lakh (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 5% growth in the latest year. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹71,260 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rascure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rascure Pharmaceuticals Private Limited
Rascure Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Srivastva | Director | 27 Oct 2021 | 5 Years 0 Months | Current |
| Ravi Pratap Singh | Director | 22 Dec 2016 | 9 Years 10 Months | Current |
| Abhishek Srivastav Also directs: Rascure India Private Limited | Director | 22 Dec 2016 | 9 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Rascure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rascure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rascure Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rascure Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Amit Kumar Srivastva was appointed as Director on 27 Oct 2021.
Frequently asked questions
Rascure Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 22 December 2016 (10+ years old) and is registered under CIN U74999DL2016PTC309584.
Rascure Pharmaceuticals has 3 current directors:
- Amit Kumar Srivastva - Director
- Ravi Pratap Singh - Director
- Abhishek Srivastav - Director
The latest financial statements of Rascure Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Rascure Pharmaceuticals is U74999DL2016PTC309584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rascure Pharmaceuticals was incorporated on 22 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Kumar Srivastva was appointed as Director on 27 Oct 2021. Abhishek Srivastav was appointed as Director on 22 Dec 2016. Ravi Pratap Singh was appointed as Director on 22 Dec 2016.
Yes, Rascure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-32-0009470).
The registered office of Rascure Pharmaceuticals is at C – 527 – A Kh.No. 96212 SF Front Side Vts Garden Chatarpur Extn., New Delhi, Delhi, India – 110074.
Rascure Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Rascure Pharmaceuticals is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.

